Track the 일양약품 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 일양약품 has published 37 public disclosures. Market capitalisation: €151.6bn. The latest transaction was filed on 28 May 2026 (Purchase). Among the most active insiders: 정유석. All data is free.
37
Insider Decl.
n/a
Thresholds
n/a
15 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,949 of 27,849 companies
47.9
score / 100
Value
53
Quality
43
FCF yld1.1%
Earn yld4.6%
EV/EBITDA11.3x
ROE8.1%
Gross mgn43%
Net mgn2.5%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.